Status:
UNKNOWN
A Multi-omics-based Metabolic Typing Study of Gastric Cancer
Lead Sponsor:
Zhejiang Cancer Hospital
Conditions:
Gastric Cancer
Multi-omics
Eligibility:
All Genders
18-80 years
Brief Summary
In the study, the investigators obtained gastric cancer tissues from 480 gastric cancer patients who had undergone surgery at the Zhejiang Cancer Hospital's biospecimen bank between 2012-2019, and obt...
Eligibility Criteria
Inclusion
- 18≤age≤80
- Histologically or cytologically confirmed gastric cancer
- Undergo surgery for radical or palliative gastric cancer (both open and laparoscopic)
- Patients with survival follow-up information
Exclusion
- Two or more kinds of malignant tumors at the same time
- Incomplete or missing case information
- Preoperative diagnosis of residual gastric cancer
Key Trial Info
Start Date :
September 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 10 2024
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT06134011
Start Date
September 10 2023
End Date
September 10 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Hangzhou, Zhejiang, China